Apellis Pharmaceuticals, Inc. (APLS)

25.25 +0.28 (+1.12%) USD  |  NASDAQ  |  Dec 29, 14:55
More

Apellis Pharmaceuticals Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. --
Fortress Biotech, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. --
Fulcrum Therapeutics, Inc. --